Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEVE.L Regulatory News (EVE)

  • There is currently no data for EVE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Eve Sleep plc: Pre-close trading update

18 Jul 2019 07:01

Eve Sleep plc (EVE) Eve Sleep plc: Pre-close trading update 18-Jul-2019 / 07:00 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.


 

 

eve Sleep plc ("eve" or the "Company")

 

 

Pre-close trading update

 

Halving of H1 loss year-on-year Robust balance sheet Launched new UK TV campaign in July New partnerships signed in July with Argos, Dunelm and Homebase On course to meet full year loss reduction expectations on slightly lower revenue growth

 

 

eve Sleep, a direct to consumer sleep wellness brand operating in the UK, Ireland (together the 'UK&I') and France, today issues a trading update for the six months ended 30 June 2019 (the 'Period').

 

Trading

 

In line with the rebuild strategy announced earlier in the year, the focus in the Period has been on reducing EBITDA losses and improving cash management. Good progress has been made in both cases. In line with Board expectations, the Underlying EBITDA1 loss reduced by 50% to £5.9m (H1 2018: -£11.9m), driven by the refocus on just three markets, greater marketing efficiency and a reduction in overheads. Net cash at the end of the Period was £12.5m.

 

As previously guided Group revenue growth for the year is expected to be second half weighted. UK&I revenues for the Period were broadly flat at 0.9% below last year, owing to the planned reduction in H1 marketing investment, as well as the challenging retail backdrop and a highly promotional mattress market. France revenues decreased 29%, reflecting the Board's decision to prioritise margin contribution over revenue growth, as well as the additional work to localise and reposition the eve brand. Group underlying revenue2 for the Period decreased by 8% to £12.9m (H1 2018: £14.1m).

 

The Board expects revenue growth to return in H2 with the launch of new marketing campaigns, three new retail partnerships and the further benefits of the rebuild strategy coming through. The Company remains on track to deliver a full year EBITDA loss reduction in line with expectations as it continues to focus on cost management, whilst full year revenue is expected to be slightly below previous guidance, owing to softer than expected market conditions in H1.

 

Strategic progress

 

Good progress is being made against the three pillars of the rebuild strategy:

 

Differentiated brand positioning: Brand continues to be a key differentiator to peers, with a new and distinctive UK campaign launched on 13 July, continuing to promote the benefits of a good night's sleep with a new endline 'eve.rise.shine.' In France there was a complete creative refresh at the end of June, including a new marketing campaign titled 'Renaissez chaque matin' (translation: Reborn every morning).

 

Expanded product range: Product development in the Period has been strong and is expected to continue through the second half, with expanded ranges across bed frames, storage, bedding and the baby collection driving on-going improvement in the KPIs of customer repeat rate and sale of non-mattress products.

 

Lower friction customer experience: The conversion rate has increased as eve continues to work on improving the entire customer journey and reducing the friction points to purchase.

 

New retail partnerships

 

Retail partnerships remain an important element of the strategy, raising brand awareness and increasing the number of places for customers to experience and purchase eve products. Since the Period end new partnerships have been signed with Argos, Dunelm and Homebase to sell eve products through their online sites. The Argos partnership is expected to commence around the end of this month, with Dunelm and Homebase launching later this summer.

 

James Sturrock, CEO of eve Sleep, commented:

 

"I am pleased with the financial and strategic progress made in H1, against a backdrop of substantial retail headwinds and the current competitive nature of the category. We have a strong new team in place, and there are early signs that the rebuild strategy is driving meaningful improvements in our key metrics in both the UK&I and France. Our focus on reducing losses, whilst creating a differentiated proposition as a sleep wellness brand, will underpin the business and lay the path to long-term profitability.

 

We have some exciting plans and partnerships launching and I look forward to seeing more progress against our strategy in some of the biggest peak trading periods for the business in the second half of the year."

 

 

Footnotes

 

1 Underlying EBITDA is defined as Group earnings before interest, tax, depreciation and amortisation and before share based payment charges. In the current year the performance relates to the three core markets of the UK&I and France. In the prior year it includes all the additional territories that eve was trading in at the time.

 

2 Group underlying revenue is defined as revenue for the core three markets of the UK&I and France for both the current and prior year periods and is used to provide a more meaningful year-on-year comparison. In July 2018, the Board reviewed the number of territories that eve traded from, deciding to focus on these three markets and withdrawing from the other territories.

 

 

 

For further information, please contact:

 

eve Sleep plc

James Sturrock, Chief Executive Officer

Tim Parfitt, Chief Financial Officer

 

 via M7 Communications LTD

finnCap Limited (NOMAD and broker)

Matt Goode (Corporate Finance)

Hannah Boros (Corporate Finance)

Alice Lane (ECM)

 

+44(0)20 7220 0500

M7 Communications LTD

Mark Reed

+44(0)7903 089 543

 

 

 


ISIN:GB00BYWMFT51
Category Code:TST
TIDM:EVE
LEI Code: 2138007BAC29AUXWQE6
Sequence No.:13787
EQS News ID:842823
 
End of AnnouncementEQS News Service

UK Regulatory announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
31st Mar 20217:01 amEQSEve Sleep plc: Director change
26th Mar 20217:00 amEQSEve Sleep plc: Director/PDMR Shareholding
22nd Mar 20217:00 amEQSEve Sleep plc: Directors Purchase of Shares
18th Mar 20217:00 amEQSEve Sleep plc: Final Results
11th Mar 202110:05 amEQSEve Sleep plc: Notice of Investor Presentation
11th Mar 20219:10 amEQSEve Sleep plc: Holding in Company
4th Mar 20212:05 pmRNSSecond Price Monitoring Extn
4th Mar 20212:00 pmRNSPrice Monitoring Extension
1st Mar 202111:05 amRNSSecond Price Monitoring Extn
1st Mar 202111:00 amRNSPrice Monitoring Extension
17th Feb 20212:06 pmRNSSecond Price Monitoring Extn
17th Feb 20212:01 pmRNSPrice Monitoring Extension
17th Feb 202111:05 amRNSSecond Price Monitoring Extn
17th Feb 202111:00 amRNSPrice Monitoring Extension
17th Feb 20219:05 amRNSSecond Price Monitoring Extn
17th Feb 20219:00 amRNSPrice Monitoring Extension
15th Feb 20214:24 pmEQSEve Sleep plc: Holding in Company
3rd Feb 20212:05 pmRNSSecond Price Monitoring Extn
3rd Feb 20212:00 pmRNSPrice Monitoring Extension
3rd Feb 202111:06 amRNSSecond Price Monitoring Extn
3rd Feb 202111:00 amRNSPrice Monitoring Extension
3rd Feb 20217:00 amEQSEve Sleep plc: Appointment of Non-Executive Director
21st Jan 20219:05 amRNSSecond Price Monitoring Extn
21st Jan 20219:00 amRNSPrice Monitoring Extension
21st Jan 20217:00 amEQSEve Sleep plc: Trading Statement
12th Jan 20218:43 amEQSEve Sleep plc: Block Listing Six Monthly Review
8th Jan 20214:40 pmRNSSecond Price Monitoring Extn
8th Jan 20214:36 pmRNSPrice Monitoring Extension
22nd Dec 202011:06 amRNSSecond Price Monitoring Extn
22nd Dec 202011:01 amRNSPrice Monitoring Extension
11th Dec 202011:05 amRNSSecond Price Monitoring Extn
11th Dec 202011:00 amRNSPrice Monitoring Extension
3rd Dec 20207:00 amEQSEve Sleep plc: Trading statement
26th Oct 20202:01 pmRNSPrice Monitoring Extension
24th Sep 20209:51 amEQSEve Sleep plc: Director/PDMR Shareholding
21st Sep 202011:05 amRNSSecond Price Monitoring Extn
21st Sep 202011:00 amRNSPrice Monitoring Extension
21st Sep 20207:00 amEQSEve Sleep plc: Non-Executive Director Change
15th Sep 20207:01 amEQSEve Sleep plc: Interim Results
11th Sep 202011:05 amRNSSecond Price Monitoring Extn
11th Sep 202011:00 amRNSPrice Monitoring Extension
3rd Sep 20202:06 pmRNSSecond Price Monitoring Extn
3rd Sep 20202:00 pmRNSPrice Monitoring Extension
3rd Sep 202011:02 amEQSEve Sleep plc: Trading statement
2nd Sep 20209:39 amEQSEve Sleep plc: Holding in Company
2nd Sep 20209:05 amRNSSecond Price Monitoring Extn
2nd Sep 20209:00 amRNSPrice Monitoring Extension
10th Aug 20202:05 pmRNSSecond Price Monitoring Extn
10th Aug 20202:00 pmRNSPrice Monitoring Extension
10th Aug 202011:05 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.